Treatment NAFLD Liver Acute arthritis Drug-induced liver injury Toxicity Hepatic stellate cell COPD Liver fibrosis Apoptosis Gut microbiota Hepatitis B Cancer Drugs Incontinence Lipid metabolism Diabetes Epidemiology Hepatitis C virus CD Lipids Guidelines Crohn's disease Infliximab Cytokines Elderly Acetaminophen Expression HepaRG Extracorporeal membrane oxygenation Anal fistula Intensive Care Units Biomarkers Hepatocellular Fatty liver-disease Adult Faecal incontinence Adolescent Spina bifida Obesity Mitochondria Cholangiocarcinoma Hepatocyte Fatty liver Radioembolization Fibrosis Cytochrome P450 Prospective Studies Metabolism Ulcerative colitis Oxidative stress Molecular networking Carcinoma Male Alcohol Cirrhosis Critical care Ethanol Intestine Anti-TNF Iron Drug metabolism Colitis Drug Detrusor overactivity Hepatic differentiation Steatosis Age Fatty acid oxidation 5mC Hemochromatosis Glucose HCC Aged France Inflammatory bowel disease Fecal incontinence Mortality Middle Aged Cytochrome P450 2E1 New psychoactive substances Prognosis Inflammation COVID-19 Hepatotoxicity Hepatocellular carcinoma Female Hepatocytes Humans Amanitin Crohn’s disease Ischemia reperfusion injury Lactate Macrophages HepaRG cells DILI Consensus Intensive care unit Outcome Chronic hepatitis C